GENE ONLINE|News &
Opinion
Blog

Business Model and Financial Strategy DecisionsLicensing, M&A, partnering, scaling-up, IPO and m

by GeneOnline
Share To
 
 

The pathways are many, the risks are varied, but the choices made early on will be critical to the future success of a growing biotech company. In this session, we have invited industry veterans and heavyweight speakers to advise on making important decisions around business model development and strategy.

Swimming with Sharks: Early Stage Biotechnology Business Models and Financing Strategies

Dr. Carter will give a talk about bioindustry development cycles and introducing the challenges and opportunities for all early-stage companies.

 

Building a Biotechnology Company through Collaboration, Licensing and M&A

Mr. Grady will address why AstraZeneca set up an innovation center in China while most western big pharma retreated. What strategies, pipelines, or disease areas so far and what can we expect from these strategies?

 

Dr. Li is a Venture Partner with Lilly Asia Ventures. He was most recently Executive VP and Global Head of Business Development at BeiGene; prior to that, he was VP of Business Development and Licensing at Merck and Executive Director of External R&D at Amgen. With over 21 years of industry experience, he will be sharing his investment strategy and insights.

 

Dr. McCracken will share his insight regarding Genentech has leveraged academic collaborations, in-licensing, out-licensing, and M&A to discover and bring its innovative medicines to patients.

 

Session organizer:

Online @ BIO Asia-Taiwan, July 23.
15:40-17:10 Taipei Time

 
Don’t miss your chance to join thousands of bioindustry professionals from Asia and around the world at BIO Asia–Taiwan 2020 Online + Live!
BIO Asia-Taiwan 2020 Secretariat

register@taiwanbio.org.tw | www.bioasiataiwan.com | +886-2-7700-3883

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top